SAM
AGIO icon

Smartleaf Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Smartleaf Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Hold
424
– – ﹤0.01% 2128
2026
Q1 		$12.6K Sell
424
-36
-8% -$1.02K ﹤0.01% 2208
2025
Q4 		$12.6K Buy
460
+62
+16% +$2.17K ﹤0.01% 2288
2025
Q3 		$15.6K Buy
398
+231
+138% +$8.69K ﹤0.01% 1920
2025
Q2 		$5.59K Sell
167
-147
-47% -$4.46K ﹤0.01% 2009
2025
Q1 		$9.51K Buy
314
+51
+19% +$1.69K ﹤0.01% 1944
2024
Q4 		$8.69K Sell
263
-130
-33% -$6.11K ﹤0.01% 2046
2024
Q3 		$17.9K Buy
393
+307
+357% +$13.9K ﹤0.01% 1411
2024
Q2 		$3.75K Buy
+86
New +$3.1K ﹤0.01% 1946

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Smartleaf Asset Management's AGIO Position: Q2 2026 in Review

Smartleaf Asset Management held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 424 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2128.

Smartleaf Asset Management first reported a position in AGIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $17.9K in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Smartleaf Asset Management held 424 shares of Agios Pharmaceuticals worth $16.1K as of Q2 2026.
  • Smartleaf Asset Management left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2128 holding.
  • Smartleaf Asset Management first reported a position in Agios Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Agios Pharmaceuticals position peaked at $17.9K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.